BE858867A - Nouveaux composes du type 1-amino-2-hydroxy-3-heterocycly-loxy-propane et procede pour leur preparation - Google Patents

Nouveaux composes du type 1-amino-2-hydroxy-3-heterocycly-loxy-propane et procede pour leur preparation

Info

Publication number
BE858867A
BE858867A BE181044A BE181044A BE858867A BE 858867 A BE858867 A BE 858867A BE 181044 A BE181044 A BE 181044A BE 181044 A BE181044 A BE 181044A BE 858867 A BE858867 A BE 858867A
Authority
BE
Belgium
Prior art keywords
heterocycly
loxy
hydroxy
amino
preparation
Prior art date
Application number
BE181044A
Other languages
English (en)
French (fr)
Original Assignee
Ciba Geigy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy filed Critical Ciba Geigy
Publication of BE858867A publication Critical patent/BE858867A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/64—One oxygen atom attached in position 2 or 6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/69—Two or more oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/84—Nitriles
    • C07D213/85—Nitriles in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/18—Oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D263/06—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
BE181044A 1976-10-05 1977-09-20 Nouveaux composes du type 1-amino-2-hydroxy-3-heterocycly-loxy-propane et procede pour leur preparation BE858867A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1263576A CH607585A5 (en) 1976-10-05 1976-10-05 Process for the preparation of 2-[3'-(2-(3,4-dimethoxy-phenyl)ethylamino)-2'-hydroxypropoxy]-3-cyanop yridine

Publications (1)

Publication Number Publication Date
BE858867A true BE858867A (fr) 1978-03-20

Family

ID=4384944

Family Applications (1)

Application Number Title Priority Date Filing Date
BE181044A BE858867A (fr) 1976-10-05 1977-09-20 Nouveaux composes du type 1-amino-2-hydroxy-3-heterocycly-loxy-propane et procede pour leur preparation

Country Status (21)

Country Link
JP (1) JPS5350177A (de)
AT (1) AT358037B (de)
AU (1) AU514676B2 (de)
BE (1) BE858867A (de)
CA (1) CA1105021A (de)
CH (1) CH607585A5 (de)
DE (1) DE2740678A1 (de)
DK (1) DK402877A (de)
ES (1) ES462389A1 (de)
FI (1) FI772681A (de)
FR (1) FR2367065A1 (de)
GB (1) GB1591723A (de)
GR (1) GR71677B (de)
IE (1) IE45692B1 (de)
IL (1) IL53013A (de)
NL (1) NL7710394A (de)
NO (1) NO773125L (de)
NZ (1) NZ185267A (de)
PT (1) PT67048B (de)
SE (1) SE7710250L (de)
ZA (1) ZA775698B (de)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0006614A3 (en) * 1978-06-27 1980-01-23 Merck & Co. Inc. Pyridyl- and imidazopyridyloxypropanolamines, process for preparing the same and pharmaceutical compositions containing the same
EP0007448A1 (de) * 1978-06-27 1980-02-06 Merck & Co. Inc. Pyridyloxypropanolamine und ihre Ester, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
EP0009075A1 (de) * 1978-06-27 1980-04-02 Merck & Co. Inc. Pyridyloxypropanolamine und ihre Ester, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzungen

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8510146D0 (en) * 1985-04-20 1985-05-30 Smith Kline French Lab Chemical compounds & processes
DE3776011D1 (de) * 1986-06-30 1992-02-27 Toyo Jozo Kk 2-substituierte alkoxy-3-substituierte pyrazine.
AU1580001A (en) * 1999-11-15 2001-05-30 Eli Lilly And Company Process for the preparation of aryloxy propanolamines

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0006614A3 (en) * 1978-06-27 1980-01-23 Merck & Co. Inc. Pyridyl- and imidazopyridyloxypropanolamines, process for preparing the same and pharmaceutical compositions containing the same
EP0007448A1 (de) * 1978-06-27 1980-02-06 Merck & Co. Inc. Pyridyloxypropanolamine und ihre Ester, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
EP0009075A1 (de) * 1978-06-27 1980-04-02 Merck & Co. Inc. Pyridyloxypropanolamine und ihre Ester, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzungen

Also Published As

Publication number Publication date
AT358037B (de) 1980-08-11
SE7710250L (sv) 1978-04-06
CH607585A5 (en) 1978-09-15
AU514676B2 (en) 1981-02-19
PT67048B (de) 1979-02-16
IE45692B1 (en) 1982-10-20
NZ185267A (en) 1979-07-11
ATA648777A (de) 1980-01-15
FR2367065B1 (de) 1980-10-10
FI772681A (fi) 1978-04-06
CA1105021A (en) 1981-07-14
GR71677B (de) 1983-06-21
JPS5350177A (en) 1978-05-08
PT67048A (de) 1977-10-01
ES462389A1 (es) 1978-07-01
DE2740678A1 (de) 1978-04-06
NO773125L (no) 1978-04-06
ZA775698B (en) 1978-05-30
FR2367065A1 (fr) 1978-05-05
NL7710394A (nl) 1978-04-07
IL53013A (en) 1981-09-13
DK402877A (da) 1978-04-06
IL53013A0 (en) 1977-11-30
GB1591723A (en) 1981-06-24
AU2912577A (en) 1979-04-05
IE45692L (en) 1978-04-05

Similar Documents

Publication Publication Date Title
BE854009A (fr) Acrylamide-amidons et procede pour leur preparation
FR2384753B1 (fr) Nouveaux thiols et leur procede de preparation
BE862578A (fr) Electrocatalyseurs et procede pour leur preparation
BE877595A (fr) Nouveaux prostenoides et procede pour leur preparation
MC1174A1 (fr) Nouveaux nucleosides et procede pour leur preparation
BE862422A (fr) Nouveaux derives de type succinimide et procede de leur preparation
BE858453A (fr) Nouveaux pentapeptides et procede pour leur preparation
FR2301528A1 (fr) Nouveaux composes 3-acyloxymethyl-cephemes et leur procede de preparation
FR2296611A1 (fr) Nouveaux composes odoriferants et leur procede de preparation
BE858867A (fr) Nouveaux composes du type 1-amino-2-hydroxy-3-heterocycly-loxy-propane et procede pour leur preparation
FR2348189A1 (fr) Nouveaux para-benzolethers basiques et procede pour leur preparation
PT69725A (fr) Procede de preparation de nouveaux composes du type muramyl-peptide
BE851681A (fr) 2,9-dioxatricyclo-4,3,03,7- decanes et procede pour leur preparation
FR2291746A1 (fr) Nouveaux composes heterocycliques et leur procede de preparation
BE867086A (fr) Composes d'azacyclyle et procede pour leur preparation
BE845057A (fr) Composes de thiaxanthene et procede pour leur preparation
FR2341568A1 (fr) Nouveaux d'homo-steroides et leur procede de preparation
BE823176A (fr) Nouveaux composes spiraniques et procede pour leur preparation
FR2330685A1 (fr) Nouveaux isoxazoles et procede pour leur preparation
FR2299034A1 (fr) Nouveaux 13-ethinyl-steroides et procede pour leur preparation
BE841469A (fr) Nouveaux composes 3-acyloxymethyl-cephem et leur procede de preparation
BE853950A (fr) Nouveaux derives de l'indazole et procede pour leur preparation
BE859309A (fr) Nouveaux esters d'hydroxymethyl-pyridine et leur procede de preparation
BE823177A (fr) Nouveaux composes spiraniques et procede pour leur preparation
FR2352833A1 (fr) Nouveaux composes tellures, procede pour leur preparation et application de ces composes

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: CIBA-GEIGY A.G.

Effective date: 19840920